Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, June 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 4 news outlets
blogs: 1 blog

twitter: 11 X users
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 44 Mendeley

Summary News Blogs X Wikipedia Dimensions citations

So far, Altmetric has seen 11 X posts from 11 X users, with an upper bound of 27,018 followers.

RT @CochraneFrance: 🤔Quelle combinaison de médicaments inhalés est sûre et efficace pour traiter la bronchopneumopathie chronique obstructi…

21 Aug 2023

Reply Repost Favourite

RT @CochraneFrance: 🤔Quelle combinaison de médicaments inhalés est sûre et efficace pour traiter la bronchopneumopathie chronique obstructi…

21 Aug 2023

Reply Repost Favourite

🤔Quelle combinaison de médicaments inhalés est sûre et efficace pour traiter la bronchopneumopathie chronique obstructive ? 📚Revue @CochraneAirways évaluant 19 études portant sur 22 354 participants ➡️Résumé disponible sur @CochraneLibrary 🔗https://t.co/P

16 Aug 2023

Reply Repost Favourite

RT @alfonso_casi: Antagonista muscarínico d acción prolongada (AMAP)+agonista beta d acción prolongada (ABAP) vs ABAP+corticosteroide inhal…

10 Jun 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.